Suppr超能文献

遗传性高血压中的肾脏钠钾ATP酶

Renal Na,K-ATPase in genetic hypertension.

作者信息

Ferrandi M, Tripodi G, Salardi S, Florio M, Modica R, Barassi P, Parenti P, Shainskaya A, Karlish S, Bianchi G, Ferrari P

机构信息

Prassis-Sigma Tau Research Institute, Settimo M.se, Milan, Italy.

出版信息

Hypertension. 1996 Dec;28(6):1018-25. doi: 10.1161/01.hyp.28.6.1018.

Abstract

Milan hypertensive rats (MHS) develop hypertension because of a primary renal alteration. Both apical and basolateral sodium transport are faster in membrane vesicles derived from renal tubules of MHS than in those of Milan normotensive control rats (MNS). These findings suggest that the increased renal sodium retention and concomitant development of hypertension in MHS may be linked to an altered transepithelial sodium transport. Since this transport is mainly under the control of the Na-K pump, we investigated whether an alteration of the enzymatic activity and/or protein expression of the renal Na,K-ATPase is detectable in prehypertensive MHS. We measured the Na,K-ATPase activity, Rb+ occlusion, turnover number, alpha 1- and beta 1-subunit protein abundance, and alpha 1 and beta 1 mRNA levels in microsomes from renal outer medulla of young (prehypertensive) and adult (hypertensive) MHS and in age-matched MNS. In both young and adult MHS, the Na,K-ATPase activity was significantly higher because of an enhanced number of active pump sites, as determined by Rb+ occlusion maximal binding. The higher number of pump sites was associated with a significant pretranslational increase of alpha 1 and beta 1 mRNA levels that preceded the development of hypertension in MHS. Since a molecular alteration of the cytoskeletal protein adducin is genetically associated with hypertension in MHS and is able to affect the actin-cytoskeleton and Na-K pump activity in transfected renal cells, we propose that the in vivo upregulation of Na-K pump in MHS is primary and linked to a genetic alteration of adducin.

摘要

米兰高血压大鼠(MHS)因原发性肾脏改变而出现高血压。与米兰正常血压对照大鼠(MNS)相比,从MHS肾小管衍生的膜囊泡中,顶端和基底外侧的钠转运都更快。这些发现表明,MHS中肾钠潴留增加和随之而来的高血压发展可能与跨上皮钠转运改变有关。由于这种转运主要受钠钾泵的控制,我们研究了在高血压前期的MHS中是否能检测到肾钠钾ATP酶的酶活性和/或蛋白质表达的改变。我们测量了年轻(高血压前期)和成年(高血压)MHS以及年龄匹配的MNS肾外髓质微粒体中的钠钾ATP酶活性、铷(Rb +)封闭、周转数、α1和β1亚基蛋白丰度以及α1和β1 mRNA水平。在年轻和成年MHS中,钠钾ATP酶活性均显著升高,这是由于通过铷(Rb +)封闭最大结合确定的活性泵位点数量增加所致。泵位点数量的增加与MHS高血压发生之前α1和β1 mRNA水平的显著翻译前增加有关。由于细胞骨架蛋白内收蛋白的分子改变在基因上与MHS中的高血压相关,并且能够影响转染肾细胞中的肌动蛋白细胞骨架和钠钾泵活性,我们提出MHS中钠钾泵的体内上调是原发性的,并且与内收蛋白的基因改变有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验